AIM: Mid-life obesity is associated with T2D risk. However, less is known about the cumulative effect of obesity during adulthood. METHODS: Framingham Offspring Study participants who had an examination at 35±2 years and were initially free of T2D were included in this study (N=1026). A cumulative excess weight (CEW) score (year*kg/m²) was calculated until T2D diagnostic or the end of follow-up. RESULTS: Eighty-four individuals (8.2%) developed T2D over 20±6 years. Mean CEW scores were 118.0±114.6 year*kg/m² in individuals who developed T2D and 30.2±91.4 year*kg/m² in those who did not develop T2D (P<0.01). T2D risk was doubled for each standard deviation increase in the CEW score (OR=1.99 [1.64-2.40]; P<0.001). However, CEW score was only significantly associated with T2D incidence for participants with a baseline BMI <25 kg/m² (OR =2.13 [1.36-3.36]; P<0.001). CONCLUSIONS: Accumulating weight between the mid-thirties to the mid-fifties increases the risk of developing T2D. However, BMI in mid-thirties remains a stronger predictor of T2D risk.
AIM: Mid-life obesity is associated with T2D risk. However, less is known about the cumulative effect of obesity during adulthood. METHODS: Framingham Offspring Study participants who had an examination at 35±2 years and were initially free of T2D were included in this study (N=1026). A cumulative excess weight (CEW) score (year*kg/m²) was calculated until T2D diagnostic or the end of follow-up. RESULTS: Eighty-four individuals (8.2%) developed T2D over 20±6 years. Mean CEW scores were 118.0±114.6 year*kg/m² in individuals who developed T2D and 30.2±91.4 year*kg/m² in those who did not develop T2D (P<0.01). T2D risk was doubled for each standard deviation increase in the CEW score (OR=1.99 [1.64-2.40]; P<0.001). However, CEW score was only significantly associated with T2D incidence for participants with a baseline BMI <25 kg/m² (OR =2.13 [1.36-3.36]; P<0.001). CONCLUSIONS: Accumulating weight between the mid-thirties to the mid-fifties increases the risk of developing T2D. However, BMI in mid-thirties remains a stronger predictor of T2D risk.
Authors: M T Guagnano; E Ballone; V Pace-Palitti; R D Vecchia; N D'Orazio; M R Manigrasso; D Merlitti; S Sensi Journal: Eur J Clin Nutr Date: 2000-04 Impact factor: 4.016
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: G Marchesini; M Cuzzolaro; E Mannucci; R Dalle Grave; M Gennaro; F Tomasi; E G Barantani; N Melchionda Journal: Int J Obes Relat Metab Disord Date: 2004-11
Authors: Amy R Weinstein; Howard D Sesso; I Min Lee; Nancy R Cook; JoAnn E Manson; Julie E Buring; J Michael Gaziano Journal: JAMA Date: 2004-09-08 Impact factor: 56.272
Authors: Jaana Lindström; Anne Louheranta; Marjo Mannelin; Merja Rastas; Virpi Salminen; Johan Eriksson; Matti Uusitupa; Jaakko Tuomilehto Journal: Diabetes Care Date: 2003-12 Impact factor: 19.112
Authors: Christine Ferrara-Cook; Susan Michelle Geyer; Carmella Evans-Molina; Ingrid M Libman; Dorothy J Becker; Stephen E Gitelman; Maria Jose Redondo Journal: Diabetes Care Date: 2020-01-14 Impact factor: 19.112
Authors: Christine T Ferrara; Susan M Geyer; Carmella Evans-Molina; Ingrid M Libman; Dorothy J Becker; John M Wentworth; Antoinette Moran; Stephen E Gitelman; Maria J Redondo Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: Christopher G Owen; Venediktos V Kapetanakis; Alicja R Rudnicka; Andrea K Wathern; Lucy Lennon; Olia Papacosta; Derek G Cook; S Goya Wannamethee; Peter H Whincup Journal: BMJ Open Date: 2015-09-15 Impact factor: 2.692
Authors: Christine Therese Ferrara; Susan Michelle Geyer; Yuk-Fun Liu; Carmella Evans-Molina; Ingrid M Libman; Rachel Besser; Dorothy J Becker; Henry Rodriguez; Antoinette Moran; Stephen E Gitelman; Maria J Redondo Journal: Diabetes Care Date: 2017-02-15 Impact factor: 19.112